Compare CCCC & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCCC | TII |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.3M | 205.9M |
| IPO Year | 2020 | N/A |
| Metric | CCCC | TII |
|---|---|---|
| Price | $2.50 | $2.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 73.3K |
| Earning Date | 11-06-2025 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | $30,108,000.00 | ★ $75,461,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.41 |
| Revenue Growth | N/A | ★ 54.36 |
| 52 Week Low | $1.09 | $0.26 |
| 52 Week High | $4.70 | $3.39 |
| Indicator | CCCC | TII |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | N/A |
| Support Level | $2.50 | N/A |
| Resistance Level | $2.69 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 23.86 | 0.00 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
Titan Mining Corp is a Canadian natural resources company. It is engaged in the acquisition, exploration, and development of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States. The Company operates one reportable segment, mineral production and exploration in the United States.